1. Intravenous Versus Oral Acetaminophen Use in Febrile Neurocritical Care Patients
- Author
-
Robert E D'Eramo, Melissa Sandler, Gretchen M. Brophy, Perry Taylor, and Pramit Nadpara
- Subjects
medicine.medical_specialty ,Neurological injury ,Fever ,urogenital system ,business.industry ,digestive, oral, and skin physiology ,Neurointensive care ,Critical Care and Intensive Care Medicine ,Acetaminophen ,Anesthesiology and Pain Medicine ,Hypothermia, Induced ,Intensive care ,parasitic diseases ,embryonic structures ,Emergency medicine ,Humans ,Medicine ,Administration, Intravenous ,business ,Ischemic Stroke ,Retrospective Studies ,medicine.drug - Abstract
The use of intravenous (IV) acetaminophen (APAP) for fever has not been thoroughly studied in neurocritical care (NCC) patients, in whom a temperature of ≥38°C is associated with poor outcomes and treatment to normothermia is common practice. This retrospective study evaluated NCC patients admitted between May 1, 2012, and April 30, 2013, and received at least one dose of IV or oral (PO) APAP for a body temperature of ≥38°C. The primary aim of this study was to compare the reduction in body temperature (RIT) between IV and PO APAP, calculated as the change in temperature before and 0.5, 1, 2, 3, and 6 hours after administration. Descriptive statistics were used to assess use characteristics, and Kruskal-Wallis and Mann-Whitney
- Published
- 2022